A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population

NCT05173883 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: injection ，CU-20401
DRUG: injection ，placebo

Sponsor

Cutia Therapeutics（Wuxi）Co.,Ltd